Related Experiment Video
Updated: Jan 8, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
Bench to Bedside: Translating Discoveries to Clinical Care in Kidney Disease
Katharine Epler1, Dana Y Fuhrman2, Sudarshan Hebbar3
1UCSD and VA San Diego Healthcare System, San Diego, California, USA.
Background:
Acute kidney injury (AKI) pathophysiology and repair are heterogenous processes, and clinical outcomes are difficult to predict. As a result, promising treatments in preclinical models have failed to translate to human subjects, and treatment options for AKI are primarily supportive.
Summary:
To address this, one of the AKI and CRRT 2025 preconference symposium plenary sessions showcased cutting-edge translational work to guide the scientific community of AKI investigators. Topics included those focused on stratifying risk for AKI reflected in the concept of kidney fitness, characterizing the molecular phenotypes of AKI, improving diagnostics, and identifying novel therapeutic targets.
Key Messages:
This article provides a review of these topics and a summary of how they address challenges to translating new therapies in AKI from bench to bedside.
Insights
Acute kidney injury (AKI) presents complex challenges in prediction and treatment. This review highlights advancements in risk stratification, molecular phenotyping, diagnostics, and therapeutics to improve AKI patient outcomes.
Area of Science:
- Nephrology
- Translational Medicine
- Biomarkers
Background:
- Acute kidney injury (AKI) exhibits heterogeneous pathophysiology and repair mechanisms, complicating clinical outcome prediction.
- Current treatment options for AKI are largely supportive, with limited success in translating preclinical findings to human subjects.
- Translational research is crucial for advancing AKI therapies from bench to bedside.
Purpose of the Study:
- To review cutting-edge translational work presented at the AKI & CRRT 2025 pre-conference symposium.
- To guide the scientific community in addressing challenges in AKI research and treatment.
- To summarize strategies for improving AKI diagnosis and therapy.
Main Methods:
- Review of plenary session topics from a specialized AKI & CRRT 2025 symposium.
- Focus on risk stratification, molecular phenotyping, diagnostics, and therapeutic targets in AKI.
- Synthesis of current translational research in acute kidney injury.
Main Results:
- Exploration of 'kidney fitness' as a concept for AKI risk stratification.
- Characterization of molecular phenotypes to better understand AKI.
- Discussion of improved diagnostics and novel therapeutic targets for AKI.
- Identification of strategies to overcome translational barriers in AKI research.
Conclusions:
- Advancements in understanding AKI heterogeneity are essential for clinical progress.
- Improved diagnostics and targeted therapeutics hold promise for AKI management.
- Translational efforts are key to developing effective AKI treatments and improving patient outcomes.
Related Concept Videos
Chronic Kidney Disease III: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Kidney Transplant I: Introduction
Chronic Kidney Disease IV: Nursing Management

